TMS Pharma
About the startup
TMS Pharma \r\n Innovating Drug Delivery dosage form for Better \r\nOutcome \r\n Contact Info +201114201461 \r\n Website https://tms-pharma.com \r\n\r\n . Company Overview \r\n TMS Pharmaceuticals is an innovative pharmaceutical \r\nstartup focused on: \r\n- Reformulating existing medications into modern, \r\npatient-friendly dosage forms. \r\n- Combining multiple active ingredients into cost\r\neffective, more compliant medications. \r\n\r\n . Problem We’re Solving \r\n- Poor adherence due to inconvenient dosage forms \r\nor multiple meds. \r\n- Need for more efficient, affordable therapies. \r\n- Issues with injectables and IV: blood-contaminated \r\nwaste, storage & recycling. \r\n difficulty in swallowing \r\n longer time of absorption , \r\n high sugar content in some medication , \r\n some dosage form lose percentage of efficacy after \r\nopening . \r\n injection may cause pain, abscess, thrombophlebitis, and \r\nthe wastes of contaminated blood syringe , cannula may \r\ncause infection. \r\n difficulty of administration of suppositories ,unpleasant \r\nexperience \r\n . Our Solution \r\n40 innovative products. \r\n- Oral dissolving films. \r\n- Compact, recyclable packaging. \r\n- No need for long clinical trials—only bioequvilance or biowaiver studies. \r\n- Licensing in 1–6 months without patent approval. \r\n https://youtu.be/okXEeGiw-3A?si=HOq6Rv-89LMhpiyi \r\n\r\n Traction & Achievements \r\n- 9patents filed, 11 in pipeline. \r\n- Market study (Egypt & GCC) \r\n - Trade name registered. \r\n- Prototype R&D and roadmap defined. \r\n\r\n . Business Model \r\n- B2B: Partnerships with distributors. \r\n- Outsourced manufacturing (CMOs.) \r\n- Export-focused after local launch. \r\n\r\n . Market Opportunity \r\n \r\n1.5 B $ market growing 5–7% annually. \r\n- Initial focus: Egypt & GCC. \r\n- Market share goal: 2% (Year 1) → 15% (Year 5)\r\n \r\nYear | Revenue | Gross Profit | Net Cash Flow \r\n 1 $ | 30 M | $7.5M | $5.83M \r\n 2 $ | 79.5 M | $19.9M | $19.9M \r\n 3 $ | 134.8 M | $40.4M | $40.4M \r\n 4 $ | 214.4 M | $75.0M | $75.0M \r\n 5 $ | 284.1 M | $99.4M | $99.4M \r\n7 . Financial Projections (USD) \r\n\r\n . Use of Funds ($1.5M) \r\n- Regulatory & lab development: $0.5M \r\n- Manufacturing & tech transfer: $0.4M \r\n- Marketing & exports: $0.4M \r\n- Legal & operational setup: $0.2M \r\n\r\n . Year 1 Milestones \r\n- Legal setup (1 month) \r\n- Lab R&D (3 months/product) \r\n - Sign 3+ CMO deals \r\n- Marketing & export agreements \r\n- File 12 more patents \r\n- License products in 1–6 months \r\n Competitive Advantage \r\n+ 22years of pharmaceutical experience. \r\n- Unique, easy-to-use formulations. \r\n- No costly clinical trials. \r\n- Scalable, low-cost production. \r\n- Reduces waste & improves storage. \r\n- Manufacture before patent approval. \r\n\r\n . Team \r\n- Founder mohamad talaat ],MBA, Certified PMI-PBA ,\r\n Pharmacist. \r\n Investment Ask \r\n- Seeking $1.5M seed funding. \r\n- Equity offered for strategic investment. \r\n- Join us in transforming medication delivery. \r\nContact \r\n Email:mohamadtmspharma.com@gmail.com \r\n Phone :+201114201461 \r\n Location: Egypt \r\nThank You!
Industry
healthtech
Sectors
healthtech